Radioimmunotherapy of fungal diseases: The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens

Joshua D. Nosanchuk, Ekaterina Dadachova

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Radioimmunotherapy is the targeted delivery of cytocidal radiation to cells via specific antibody. Although mature for the treatment of cancer, RIT of infectious diseases is in preclinical development. However, as there is an obvious and urgent need for novel approaches to treat infectious diseases, RIT can provide us with a powerful approach to combat serious diseases, including invasive fungal infections. For example, RIT has proven more effective than standard amphotericin B for the treatment of experimental cryptococcosis. This review will discuss the concepts of RIT its applications for infectious diseases, and the strides made to date to bring RIT of infectious diseases to fruition. Finally, we will discuss the potential of PAN-FUNGAL RIT the targeting of conserved fungal cell surface antigens by RIT as a treatment modality for fungi prior to the formal microbiological identification of the specific pathogen. In sum, RIT provides a mechanism for the targeted killing of drug susceptible or resistant fungi irrespective of the host immune status and may dramatically reduce the length of therapy currently required for many invasive fungal diseases.

Original languageEnglish (US)
Article numberArticle 283
JournalFrontiers in Microbiology
Volume2
Issue numberJAN
DOIs
StatePublished - 2012

Fingerprint

Fungal Antibodies
Radioimmunotherapy
Mycoses
Surface Antigens
Communicable Diseases
Radiation
Fungi
Cryptococcosis
Amphotericin B
Therapeutics
Antibodies
Pharmaceutical Preparations
Neoplasms

Keywords

  • Antibody
  • Beta-glucan
  • Candida albicans
  • Cryptococcus neoformans
  • Heat shock protein 60
  • Histoplasma capsulatum
  • Melanin

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

@article{166b28fd3eff4dd7a1de4d853e0678e1,
title = "Radioimmunotherapy of fungal diseases: The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens",
abstract = "Radioimmunotherapy is the targeted delivery of cytocidal radiation to cells via specific antibody. Although mature for the treatment of cancer, RIT of infectious diseases is in preclinical development. However, as there is an obvious and urgent need for novel approaches to treat infectious diseases, RIT can provide us with a powerful approach to combat serious diseases, including invasive fungal infections. For example, RIT has proven more effective than standard amphotericin B for the treatment of experimental cryptococcosis. This review will discuss the concepts of RIT its applications for infectious diseases, and the strides made to date to bring RIT of infectious diseases to fruition. Finally, we will discuss the potential of PAN-FUNGAL RIT the targeting of conserved fungal cell surface antigens by RIT as a treatment modality for fungi prior to the formal microbiological identification of the specific pathogen. In sum, RIT provides a mechanism for the targeted killing of drug susceptible or resistant fungi irrespective of the host immune status and may dramatically reduce the length of therapy currently required for many invasive fungal diseases.",
keywords = "Antibody, Beta-glucan, Candida albicans, Cryptococcus neoformans, Heat shock protein 60, Histoplasma capsulatum, Melanin",
author = "Nosanchuk, {Joshua D.} and Ekaterina Dadachova",
year = "2012",
doi = "10.3389/fmicb.2011.00283",
language = "English (US)",
volume = "2",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "JAN",

}

TY - JOUR

T1 - Radioimmunotherapy of fungal diseases

T2 - The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens

AU - Nosanchuk, Joshua D.

AU - Dadachova, Ekaterina

PY - 2012

Y1 - 2012

N2 - Radioimmunotherapy is the targeted delivery of cytocidal radiation to cells via specific antibody. Although mature for the treatment of cancer, RIT of infectious diseases is in preclinical development. However, as there is an obvious and urgent need for novel approaches to treat infectious diseases, RIT can provide us with a powerful approach to combat serious diseases, including invasive fungal infections. For example, RIT has proven more effective than standard amphotericin B for the treatment of experimental cryptococcosis. This review will discuss the concepts of RIT its applications for infectious diseases, and the strides made to date to bring RIT of infectious diseases to fruition. Finally, we will discuss the potential of PAN-FUNGAL RIT the targeting of conserved fungal cell surface antigens by RIT as a treatment modality for fungi prior to the formal microbiological identification of the specific pathogen. In sum, RIT provides a mechanism for the targeted killing of drug susceptible or resistant fungi irrespective of the host immune status and may dramatically reduce the length of therapy currently required for many invasive fungal diseases.

AB - Radioimmunotherapy is the targeted delivery of cytocidal radiation to cells via specific antibody. Although mature for the treatment of cancer, RIT of infectious diseases is in preclinical development. However, as there is an obvious and urgent need for novel approaches to treat infectious diseases, RIT can provide us with a powerful approach to combat serious diseases, including invasive fungal infections. For example, RIT has proven more effective than standard amphotericin B for the treatment of experimental cryptococcosis. This review will discuss the concepts of RIT its applications for infectious diseases, and the strides made to date to bring RIT of infectious diseases to fruition. Finally, we will discuss the potential of PAN-FUNGAL RIT the targeting of conserved fungal cell surface antigens by RIT as a treatment modality for fungi prior to the formal microbiological identification of the specific pathogen. In sum, RIT provides a mechanism for the targeted killing of drug susceptible or resistant fungi irrespective of the host immune status and may dramatically reduce the length of therapy currently required for many invasive fungal diseases.

KW - Antibody

KW - Beta-glucan

KW - Candida albicans

KW - Cryptococcus neoformans

KW - Heat shock protein 60

KW - Histoplasma capsulatum

KW - Melanin

UR - http://www.scopus.com/inward/record.url?scp=84875773694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875773694&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2011.00283

DO - 10.3389/fmicb.2011.00283

M3 - Article

C2 - 22275913

AN - SCOPUS:84875773694

VL - 2

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - JAN

M1 - Article 283

ER -